EPO Enlarged Board rejects software patent referral

01 June 2010

Emma Barraclough, London

The EPO's Enlarged Board has ruled that there is no conflict in the Office's case law over the patenting of computer-implemented inventions, in a decision welcomed by patent attorneys.

After reviewing a series of opinions by its Technical Boards of Appeal, the seven-member Enlarged Board concluded in a 61-page decision that there was no divergence, and that questions referred by President Alison Brimelow on the issue were therefore inadmissible.

In its ruling, the Enlarged Board compared the concept of legal development with the notion of "different decision".

"[L]egal development as such cannot on its own form the basis for a referral, only because case law in new legal and/or technical fields does not always develop in linear fashion, and earlier approaches may be abandoned or modified."

In October 2008, Brimelow formally asked the Enlarged Board to consider a set of questions concerning the patentability of...



Only subscribers have complete access to Managing IP Magazine, log in or subscribe now.

Alternatively take a free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).

Subscribe Now

This article is available to subscribers. Please click subscribe to read the rest of the article.

Subscribe

Take a free trial

Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.

Take a free trial


INTA Daily News 2012

Read this year's INTA Daily News - published daily by Managing IP direct from the 134th INTA Annual Meeting in Washington DC

null null null
null null

May 2012

Do you want to be famous?

Famous, well-known, notorious, reputed: everyone wants enhanced protection for their trade marks. But should they, and what does it mean if it is? Emma Barraclough explains



Most read articles

Poll

Will the new post grant and inter partes review proceedings result in more litigators practising pro hac vice before the USPTO?







Supplements